26Feb/23
Overcoming On-Target Off-Tumor Toxicity of CAR T-Cell Therapy for Solid Tumors
The success of CAR T cells in treating hematologic malignancies has provided impetus for the development of CAR T therapies in solid tumors. The biggest obstacle to the development of CAR TRead More…